G Okan, S Yaylaci, S Alzafer. Show Affiliations »
Abstract
Mesh： See more » Antitubercular Agents/adverse effectsAntitubercular Agents/therapeutic useFemaleHumansIsoniazid/adverse effectsIsoniazid/therapeutic useMiddle AgedPellagra/complicationsPellagra/drug therapyPellagra/epidemiologyPyridoxine/administration & dosagePyridoxine/therapeutic useTuberculosis, Pulmonary/complicationsTuberculosis, Pulmonary/drug therapy
Substances： See more » Antitubercular AgentsPyridoxineIsoniazid
Year: 2008 PMID： 18624875 DOI： 10.1111/j.1468-3083.2008.02883.x
Source DB: PubMed Journal: J Eur Acad Dermatol Venereol ISSN： 0926-9959 Impact factor: 6.166